Researchers from the University of Warwick in Coventry, United Kingdom have developed a new antiviral using naturally occurring influenza virus "protecting virus" that may defend against any influenza A virus in any animal host. They report their findings in the September 2008 issue of the Journal of Virology.
Human influenza virus A is not only responsible for seasonal disease in humans, it is also the cause of worldwide pandemics of which the last three resulted in millions of deaths all over the globe. Currently, live and killed vaccines countering specific strains of the flu are available, however a vaccine for a new pandemic strain would take months to develop. Also, increased resistance to antivirals currently on the market has emphasized the need for a new effective prophylactic and therapeutic treatment method.
The "protecting virus" contains an altered gene that makes it harmless and prevents it from reproducing in a cell. If another influenza virus invades the cell it still remains harmless, but rapidly reproduces and prevents infection by literally crowding out the new influenza strain.
In the study researchers used a "protecting virus" (known as 244) as an influenza A antiviral therapy and tested it in mice. A 120-ng intranasal dose completely protected mice simultaneously challenged with 10 50 percent lethal doses of influenza A/WSN (H1N1) virus. The 244 protecting virus also protected mice against strong doses of H2N2, H3N2, and H3N8. Prophylactic activity was maintained in mice at least 1 week prior to challenge and a clear therapeutic benefit was observed when administered 24 to 48 hours following a lethal challenge. Finally, the 244 protecting virus was noted to be 10- to 100-fold more active than previous defective influenza A viruses.
Reference: Dimmock NJ, Rainsford EW, Scott PD, Marriot AC. Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral. J Virology. 82;17: 8570-8578. 2008.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.
2 Commerce Drive
Cranbury, NJ 08512